GEMTESA is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Urovant Sciences, Inc.. The primary component is Vibegron.
Product ID | 73336-075_1dc55414-952a-420f-9cfb-8eb776917946 |
NDC | 73336-075 |
Product Type | Human Prescription Drug |
Proprietary Name | GEMTESA |
Generic Name | Vibegron |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2020-12-29 |
Marketing Category | NDA / NDA |
Application Number | NDA213006 |
Labeler Name | Urovant Sciences, Inc. |
Substance Name | VIBEGRON |
Active Ingredient Strength | 75 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2020-12-29 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
GEMTESA 79329263 not registered Live/Pending |
Urovant Sciences GmbH 2021-10-25 |
GEMTESA 79246577 not registered Live/Pending |
Urovant Sciences GmbH 2018-11-01 |